Biotech · Public company · La Jolla, CA, US
Medicinova Inc
Ticker MNOV · SEC CIK 0001226616
Track this companyFree. Adds Medicinova Inc to your Dealase workspace and tells you when its record changes.
Clinical trials142 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline11
- MN-166Phase 3 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ibudilastPhase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- ibudilastPhase 2 · Multiple Sclerosis, Primary ProgressiveClinicalTrials.gov · fetched Nov 12, 2026
- IbudilastPhase 2 · Pneumonia, ViralClinicalTrials.gov · fetched Nov 12, 2026
- MN-001Phase 2 · Non-alcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
- MN-001Phase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- MN-001Phase 2 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- MN-166Phase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- riluzolePhase 2 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- TemozolomidePhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- MN-166Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials14
- MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaPHASE2 · ACTIVE_NOT_RECRUITING · started Aug 22, 2022ClinicalTrials.gov NCT05464784 · fetched Nov 12, 2026
- Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSPHASE2 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04429555 · fetched Nov 12, 2026
- Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started May 28, 2020ClinicalTrials.gov NCT04057898 · fetched Nov 12, 2026
- Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy VolunteersPHASE1 · COMPLETED · started Jun 24, 2019ClinicalTrials.gov NCT04054206 · fetched Nov 12, 2026
- Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent GlioblastomaPHASE1_PHASE2 · COMPLETED · started Dec 29, 2018ClinicalTrials.gov NCT03782415 · fetched Nov 12, 2026
- Ibudilast for the Treatment of Alcohol Use DisorderPHASE2 · COMPLETED · started Oct 1, 2018ClinicalTrials.gov NCT03594435 · fetched Nov 12, 2026
- Study of MN-166 (Ibudilast) Extended Release Tablet Formulations Compared With Capsules in Healthy VolunteersPHASE1 · COMPLETED · started Apr 11, 2018ClinicalTrials.gov NCT03533387 · fetched Nov 12, 2026
- A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)PHASE1_PHASE2 · COMPLETED · started May 6, 2016ClinicalTrials.gov NCT02714036 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary FibrosisPHASE2 · COMPLETED · started Mar 9, 2016ClinicalTrials.gov NCT02503657 · fetched Nov 12, 2026
- Open-Label Study To Evaluate MN-001 on HDL & Triglyceride in NASH & NAFLD SubjectsPHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02681055 · fetched Nov 12, 2026
- Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)PHASE2 · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02238626 · fetched Nov 12, 2026
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisPHASE2 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01982942 · fetched Nov 12, 2026
- Safety Interaction Trial Ibudilast and MethamphetaminePHASE1 · COMPLETED · started Jan 1, 2011ClinicalTrials.gov NCT01217970 · fetched Nov 12, 2026
- Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALSNO_LONGER_AVAILABLEClinicalTrials.gov NCT06743776 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 19, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 24, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 14, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 10, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 30, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026
- S-1 · S-1SEC EDGAR · filed Aug 22, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026